ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 151 filers reported holding ARCUS BIOSCIENCES INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $222 | -66.2% | 12,184 | -61.7% | 0.00% | -62.5% |
| Q4 2022 | $657 | -99.9% | 31,789 | -15.4% | 0.01% | -20.0% |
| Q2 2022 | $952,000 | -68.0% | 37,557 | -60.1% | 0.01% | -54.5% |
| Q1 2022 | $2,973,000 | +183.7% | 94,186 | +263.8% | 0.02% | +266.7% |
| Q4 2021 | $1,048,000 | +10.9% | 25,889 | -4.4% | 0.01% | +50.0% |
| Q3 2021 | $945,000 | +367.8% | 27,090 | +276.2% | 0.00% | +300.0% |
| Q1 2021 | $202,000 | -34.4% | 7,201 | -39.3% | 0.00% | -50.0% |
| Q4 2020 | $308,000 | -44.7% | 11,869 | -63.5% | 0.00% | -50.0% |
| Q3 2020 | $557,000 | +53.4% | 32,526 | +121.8% | 0.00% | +33.3% |
| Q2 2020 | $363,000 | +124.1% | 14,663 | +25.3% | 0.00% | +50.0% |
| Q1 2020 | $162,000 | +47.3% | 11,698 | +33.2% | 0.00% | +100.0% |
| Q1 2019 | $110,000 | – | 8,782 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |